Top

Indian Journal of Hematology and Blood Transfusion

Published in:

01-06-2017 | Original Article

Usefulness of Reticulocyte Parameters for Diagnosis of Hereditary Spherocytosis in Children

Authors: Olga Ciepiela, Anna Adamowicz-Salach, Andżelika Radgowska, Katarzyna Żbikowska, Iwona Kotuła

Published in: Indian Journal of Hematology and Blood Transfusion | Issue 2/2017

Abstract

Innovations in laboratory equipment have enabled a widening of the spectrum of hematological parameters obtained from single measurements of peripheral blood samples, including reticulocyte parameters. The usefulness of reticulocytes indices to confirm the diagnosis of pediatric anemia was analyzed in this study. The study group consisted of 163 children, aged 1 month–17 years, with anemia. Complete blood count extended with an analysis of reticulocyte parameters were measured using a Beckman Coulter LH 750. The mean sphered corpuscular volume (MSCV) in the group of children with hereditary spherocytosis (HS) was 66.71 ± 8.45 fL, whereas in other anemic patients MSCV was 87.76 ± 11.22 fL, p < 0.0001. In HS children the average mean corpuscular volume of red blood cells was higher than the MSCV value, while an inverse correlation was observed in the group of children with other anemias, p < 0.0001. A significant difference was found between the ratio of absolute reticulocyte count and IRF fraction (Ret#/IRF)—0.6 ± 0.28 in the HS group and 0.23 ± 0.16 in the non-HS group, respectively. Our results suggest that analysis of reticulocyte parameters is useful in the diagnosis of anemia and should be included in the routine CBC analysis in anemic children.

International Council for Standardization in Hematology, Writing Group, Briggs C, Culp N, Davis B, d’Onofrio G, Zini G, Machin SJ, International Council for Standardization of Hematology (2014) ICSH guidelines for the evaluation of blood cell analysers including those used for differential leucocyte and reticulocyte counting. Int J Lab Hematol 36(6):613–627CrossRef

Broséus J, Visomblain B, Guy J, Maynadié M, Girodon F (2010) Evaluation of mean sphered corpuscular volume for predicting hereditary spherocytosis. Int J Lab Hematol 32(5):519–523CrossRefPubMed

Ceylan C, Miskioğlu M, Colak H, Kiliççioğlu B, Ozdemir E (2007) Evaluation of reticulocyte parameters in iron deficiency, vitamin B(12) deficiency and beta-thalassemia minor patients. Int J Lab Hematol 29(5):327–334CrossRefPubMed

Chouliaras GL, Stamoulakatou A, Tsiftis G, Perissaki G, Premetis E, Lycopoulou L (2010) Age, beta thalassaemia trait, and iron-deficient anemia significantly affect reticulocyte indices in pre-school children. Eur J Pediatr 169(9):1097–1104CrossRefPubMed

Hoffmann JJ, van den Broek NM, Curvers J (2012) Reference intervals of extended erythrocyte and reticulocyte parameters. Clin Chem Lab Med 50(5):941–948CrossRefPubMed

Lazarova E, Pradier O, Cotton F, Gulbis B (2014) Automated reticulocyte parameters for hereditary spherocytosis screening. Ann Hematol 93(11):1809–1818CrossRefPubMed

Maconi M, Cavalca L, Danise P, Cardarelli F, Brini M (2009) Erythrocyte and reticulocyte indices in iron deficiency in chronic kidney disease: comparison of two methods. Scand J Clin Lab Investig 69(3):365–370CrossRef

Mullier F, Lainey E, Fenneteau O, Da Costa L, Schillinger F, Bailly N, Cornet Y, Chatelain C, Dogne JM, Chatelain B (2011) Additional erythrocytic and reticulocytic parameters helpful for diagnosis of hereditary spherocytosis: results of a multicentre study. Ann Hematol 90(7):759–768CrossRefPubMed

Ng EH, Leung JH, Lau YS, Ma ES (2015) Evaluation of the new red cell parameters on Beckman Coulter DxH800 in distinguishing iron deficiency anemia from thalassaemia trait. Int J Lab Hematol 37(2):199–207CrossRefPubMed

10.

Ntaios G, Chatzinikolaou A (2009) Incorporation of erythrocytic and reticulocytic parameters in a common formula: will it provide a more accurate differentiation between iron deficiency anemia and beta-thalassemic trait? Int J Lab Hematol 31(5):579–580CrossRefPubMed

11.

Osta V, Caldirola MS, Fernandez M, Marcone MI, Tissera G, Pennesi S, Ayuso C (2013) Utility of new mature erythrocyte and reticulocyte indices in screening for iron-deficiency anemia in a pediatric population. Int J Lab Hematol 35(4):400–405CrossRefPubMed

12.

Parodi E, Giraudo MT, Davitto M, Ansaldi G, Mondino A, Garbarini L, Franzil A, Mazzone R, Russo G, Ramenghi U (2012) Reticulocyte parameters: markers of early response to oral treatment in children with severe iron-deficiency anemia. J Pediatr Hematol Oncol 34(6):e249–e252CrossRefPubMed

13.

Urrechaga E, Borque L, Escanero JF (2011) Analysis of reticulocyte parameters on the Sysmex XE 5000 and LH 750 analyzers in the diagnosis of inefficient erythropoiesis. Int J Lab Hematol 33(1):37–44CrossRefPubMed

14.

Urrechaga E, Borque L, Escanero JF (2013) Erythrocyte and reticulocyte indices in the assessment of erythropoiesis activity and iron availability. Int J Lab Hematol 35(2):144–149CrossRefPubMed

15.

Urrechaga E, Borque L, Escanero JF (2010) Erythrocyte and reticulocyte indices on the LH750 as potential markers of iron deficiency. Anemia 2010:625919. doi:10.1155/2010/625919 CrossRefPubMedPubMedCentral

16.

Urrechaga E, Borque L, Escanero JF (2011) Erythrocyte and reticulocyte parameters in iron deficiency and thalassemia. J Clin Lab Anal 25(3):223–238CrossRefPubMed

17.

Urrechaga E (2009) Clinical utility of the new Beckman-Coulter parameter red blood cell size factor in the study of erithropoiesis. Int J Lab Hematol 31(6):623–629CrossRefPubMed

18.

Ermens AA, Hoffmann JJ, Krockenberger M, Van Wijk EM (2012) New erythrocyte and reticulocyte parameters on CELL-DYN Sapphire: analytical and preanalytical aspects. Int J Lab Hematol 34(3):274–282CrossRefPubMed

19.

Chiron M, Cynober T, Mielot F, Tchernia G, Croisille L (1999) The GEN.S: a fortuitous finding of a routine screening test for hereditary spherocytosis. Hematol Cell Ther 41(3):113–116CrossRefPubMed

20.

Bolton-Maggs PHB, Langer JC, Iolascon A, Tittensor P, King M-J (2011) Guidelines for the diagnosis and management of hereditary spherocytosis—2011 update. Br J Haematol 156:37–49CrossRefPubMed

21.

Rooney S, Hoffmann JJ, Cormack OM, McMahon C (2015) Screening and confirmation of hereditary spherocytosis in children using a CELL-DYN Sapphire hematology analyser. Int J Lab Hematol 37(1):98–104CrossRefPubMed

22.

Gołebiowska-Staroszczyk S, Matysiak M, Adamowicz-Salach A, Sobocińska-Mirska A, Szmydki-Baran A, Romiszewski M (2009) Erythropoietin treatment of infants with anemia in the first three months of life. Med Wieku Rozwoj 13(4):270–276PubMed

23.

Ghosh K, Colah R, Manglani M, Choudhry VP, Verma I, Madan N, Saxena R, Jain D, Marwaha N, Das R, Mohanty D, Choudhary R, Agarwal S, Ghosh M, Ross C (2014) Guidelines for screening, diagnosis and management of hemoglobinopathies. Indian J Hum Genet 20(2):101–119CrossRefPubMedPubMedCentral

24.

King MJ, Garçon L, Hoyer JD, Iolascon A, Picard V, Stewart G, Bianchi P, Lee SH, Zanella A, International Council for Standardization in Haematology (2015) ICSH guidelines for the laboratory diagnosis of nonimmune hereditary red cell membrane disorders. Int J Lab Hematol 37(3):304–325CrossRefPubMed

25.

National Clinical Guideline Centre (UK) (2015) Anaemia management in chronic kidney disease: partial update 2015 [internet]. National Institute for Health and Care Excellence: Clinical Guidelines

26.

Peyrin-Biroulet L, Williet N, Cacoub P (2015) Guidelines on the diagnosis and treatment of iron deficiency across indications: a systematic review. Am J Clin Nutr 102(6):1585–1594CrossRefPubMed

27.

Tao YF, Deng ZF, Liao L, Qiu YL, Chen WQ, Lin FQ (2015) Comparison and evaluation of three screening tests of hereditary spherocytosis in Chinese patients. Ann Hematol 94(5):747–751CrossRefPubMed

28.

Costa E, Rocha S, Rocha-Pereira P, Castro E, Miranda V, do Sameiro Faria M, Loureiro A, Quintanilha A, Belo L, Santos-Silva A (2008) Altered erythrocyte membrane protein composition in chronic kidney disease stage 5 patients under haemodialysis and recombinant human erythropoietin therapy. Blood Purif 26(3):267–273CrossRefPubMed

29.

Brzeszczynska J, Luciak M, Gwozdzinski K (2008) Alterations of erythrocyte structure and cellular susceptibility in patients with chronic renal failure: effect of haemodialysis and oxidative stress. Free Radic Res 42(1):40–48CrossRefPubMed

30.

Salvagno GL, Sanchis-Gomar F, Picanza A, Lippi G (2014) Red blood cell distribution width: a simple parameter with multiple clinical applications. Crit Rev Clin Lab Sci 23:1–20

31.

Polanska B, Makulska I, Augustyniak D, Niemczuk M, Zwolinska D, Jankowski A (2007) Serum levels of MMP-9 in children and young adults with chronic kidney disease treated conservatively and undergoing hemodialysis. Cent Eur J Immunol 32(2):66–71

32.

Bogin E, Massry SG, Levi J, Djaldeti M, Bristol G, Smith J (1982) Effect of parathyroid hormone on osmotic fragility of human erythrocytes. J Clin Investig 69(4):1017–1025CrossRefPubMedPubMedCentral

33.

Koşan C, Sever L, Arisoy N (2004) Lack of relation between serum parathyroid hormone levels and erythrocyte osmotic fragility in pediatric patients on peritoneal dialysis. Ren Fail 26(6):683–687CrossRefPubMed

34.

Nair SC, Arora N, Jain S, Inbakumar D, Mammen J, Sitaram U (2015) Mean reticulocyte volume enhances the utility of red cell mean sphered cell volume in differentiating peripheral blood spherocytes of hereditary spherocytosis from other causes. Indian J Pathol Microbiol 58(3):307–309CrossRefPubMed

Title: Usefulness of Reticulocyte Parameters for Diagnosis of Hereditary Spherocytosis in Children
Authors: Olga Ciepiela
Anna Adamowicz-Salach
Andżelika Radgowska
Katarzyna Żbikowska
Iwona Kotuła
Publication date: 01-06-2017
Publisher: Springer India
Published in: Indian Journal of Hematology and Blood Transfusion / Issue 2/2017
Print ISSN: 0971-4502
Electronic ISSN: 0974-0449
DOI: https://doi.org/10.1007/s12288-016-0680-0

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 2/2017

Bullous Pyoderma Gangrenosum Associated with Hairy Cell Leukemia and Its Complete Response to Cladribine Therapy

A Correlation of the Platelet Count with D-Dimer Levels as an Indicator for Component Therapy in Children with Dengue Hemorrhagic Fever

Clinically Significant IgM Anti-Cw: A Rare Report

Highlights of Multiple Myeloma at the Annual Meeting of American Society of Hematology, 2016

Growth Factor Variation in Two Types of Autologous Platelet Biomaterials: PRP Versus PRF

Evaluation of Bone Marrow Microvessel Density in Patients with Aplastic Anemia

Keynote webinar | Spotlight on antibody–drug conjugates in cancer